Pseudoacromegaly induced by the long-term use of minoxidil

Journal of the American Academy of Dermatology

Volumn 48, Issue 6, 2003, Pages 962-965

  Nguyen, Kari H ^a   Marks Jr , James G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FUROSEMIDE; GROWTH HORMONE; LABETALOL; LANSOPRAZOLE; MINOXIDIL; POTASSIUM; QUINAPRIL; SIMVASTATIN; SPIRONOLACTONE;

ACROMEGALY; ADENOHYPOPHYSIS; ADULT; ARTICLE; BONE; CARTILAGE; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY DISEASE; DRUG MEGADOSE; FACE; FOREHEAD; GROWTH HORMONE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSEUDOACROMEGALY; SCALP; SKINFOLD; SOFT TISSUE;

EID: 0038792658     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2003.325     Document Type: Article

References (17)

1. Veznedaroglu E, Armonda RA, Andrews DW. Diagnosis and therapy for pituitary tumors. Curr Opin Oncol 1999;11:27-31.
2. Gayle C, Sonksen P. The presentation of acromegaly in general practice. Practitioner 1999;243:110-1,114,116-7.
3. Freinkel RK. Other endocrine diseases. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, et al, editors. Fitzpatrick's dermatology in general medicine. New York: McGraw-Hill; 1999. p. 1976-86.
4. Barkan AL. New options for diagnosing and treating acromegaly. Cleve Clin J Med 1998;65:343,347-9.
5. Kausch D, Bergemann C, Hamann A, Matthaei S. Insulin-mediated pseudoacromegaly in a patient with severe resistance: association of defective insulin-stimulated glucose transport with impaired phosphatidylinositol 3-kinase activity in fibroblasts. Exp Clin Endocrinol Diabetes 1999;107:148-54.
6. Dib K, Whitehead JP, Humphreys PJ, Soos MA, Baynes KC, Kumar S, et al. Impaired activation of phosphoinositide 3-kinase by insulin in fibroblasts from patients with severe insulin resistance and pseudoacromegaly: a disorder characterized by selective postreceptor insulin resistance. J Clin Invest 1998;101:1111-20.
7. Kumar S, Durrington PN, O'Rahilly S, Laing I, Humphreys PJ, Olukoga AO, et al. Severe insulin resistance, diabetes mellitus, hypertriglyceridemia, and pseudoacromegaly. J Clin Endocrinol Metab 1996;81:3456-8.
8. Flier JS, Moller DE, Moses AC, O'Rahilly S, Chaiken RL, Grigorescu F, et al. Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resistance. J Clin Endocrinol Metab 1993;76:1533-41.
9. Kozlova SI, Altshuler BA, Kravchenko VL. Self-limited autosomal recessive syndrome of skin ulceration, arthroosteolysis with pseudoacromegaly, keratitis, and oligodontia in a Kirghizian family. Am J Med Genetics 1983;15:205-10.
10. Anonymous. Minoxidil (Loniten). Med Lett Drugs Ther 1980;22:21-2.
11. Oates JA. Antihypertensive agents and the drug therapy of hypertension. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, editors. Goodman & Gilman's: the pharmacological basis of therapeutics. New York: McGraw-Hill; 1996. p. 780-808.
12. Mori Y, Hamamoto T, Otomo S. Sulfation of minoxidil in keratinocytes and hair follicles and the stimulatory effect of minoxidil on the biosynthesis of glycosaminoglycans. Ann N Y Acad Sci 1991;642:473-5.
13. Tajima S, Hayashi A, Suzuki T, Nishikawa T. Stimulation of elastin expression by minoxidil in chick skin fibroblasts. Arch Dermatol Res 1995;287:494-7.
14. Murad S, Pinnell SR. Suppression of fibroblast proliferation and lysyl hydroxylase activity by minoxidil. J Biol Chem 1987;262:11973-8.
15. Priestley GC, Aldridge RD, Sime PJ, Wilson D. Skin fibroblast activity in pretibial myxoedema and the effect of octreotide (Sandostatin) in vitro. Br J Dermatol 1994;131:52-6.
16. Priestley GC, Lord RL, Stavropoulos P. The metabolism of fibro-blasts from normal and fibrotic skin is inhibited by minoxidil in vitro. Br J Dermatol 1991;125:217-21.
17. Thiboutot DM. Dermatological manifestations of endocrine disorders. J Clin Endocrinol Metab 1995;80:3082-7.